MidFirst Bank’s AbbVie ABBV Stock Holding History

MidFirst Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Buy	41,007 +723	+2%	+$156K	0.73%	34
2026 Q1	$8.76M	Sell	40,284 -2,574	-6%	-$571K	0.73%	38
2025 Q4	$9.24M	Buy	+42,858	New	+$9.76M	0.74%	33

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MidFirst Bank's ABBV Position: Q2 2026 in Review

MidFirst Bank increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $156K and bringing the position to 41,007 shares worth $10.3M. The position accounts for 0.73% of the portfolio, ranked #34.

MidFirst Bank first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 3,690 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MidFirst Bank held 41,007 shares of AbbVie worth $10.3M as of Q2 2026.
MidFirst Bank bought 723 AbbVie shares in Q2 2026, an estimated $156K.
AbbVie made up 0.73% of MidFirst Bank's portfolio in Q2 2026, its #34 holding.
MidFirst Bank first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
3,690 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.